ATE338062T1 - Neuronale, die exozytose hemmende peptide und diese enthaltende kosmetische und pharmazeutische zusammensetzungen - Google Patents
Neuronale, die exozytose hemmende peptide und diese enthaltende kosmetische und pharmazeutische zusammensetzungenInfo
- Publication number
- ATE338062T1 ATE338062T1 AT00905076T AT00905076T ATE338062T1 AT E338062 T1 ATE338062 T1 AT E338062T1 AT 00905076 T AT00905076 T AT 00905076T AT 00905076 T AT00905076 T AT 00905076T AT E338062 T1 ATE338062 T1 AT E338062T1
- Authority
- AT
- Austria
- Prior art keywords
- cosmetic
- pharmaceutical compositions
- neuronal exocytosis
- compositions containing
- containing same
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000028023 exocytosis Effects 0.000 title abstract 3
- 230000001537 neural effect Effects 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 102000004183 Synaptosomal-Associated Protein 25 Human genes 0.000 abstract 2
- 108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 abstract 2
- 230000001575 pathological effect Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000001815 facial effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009900844A ES2160485B1 (es) | 1999-04-23 | 1999-04-23 | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338062T1 true ATE338062T1 (de) | 2006-09-15 |
Family
ID=8308129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00905076T ATE338062T1 (de) | 1999-04-23 | 2000-02-18 | Neuronale, die exozytose hemmende peptide und diese enthaltende kosmetische und pharmazeutische zusammensetzungen |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7015192B1 (de) |
| EP (1) | EP1180524B2 (de) |
| JP (2) | JP4363556B2 (de) |
| AT (1) | ATE338062T1 (de) |
| AU (1) | AU2672900A (de) |
| BR (2) | BR0011152A (de) |
| CA (1) | CA2370289C (de) |
| DE (1) | DE60030429T3 (de) |
| DK (1) | DK1180524T4 (de) |
| ES (1) | ES2160485B1 (de) |
| PT (1) | PT1180524E (de) |
| WO (1) | WO2000064932A1 (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2160485B1 (es) * | 1999-04-23 | 2002-05-16 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
| DK1301213T3 (en) | 2000-07-21 | 2017-03-27 | Revance Therapeutics Inc | MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT |
| US7332567B2 (en) * | 2001-08-28 | 2008-02-19 | Allergan, Inc. | Fret protease assays for clostridial toxins |
| US7071167B2 (en) | 2002-11-13 | 2006-07-04 | L'oreal | Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines |
| FR2846885B1 (fr) * | 2002-11-13 | 2004-12-24 | Oreal | Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules |
| JP2004323400A (ja) * | 2003-04-23 | 2004-11-18 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
| BRPI0508440A (pt) | 2004-03-03 | 2007-07-24 | Revance Therapeutics Inc | composições e métodos para diagnóstico tópico e transporte terapêutico |
| HUE025656T2 (en) | 2004-03-03 | 2016-04-28 | Revance Therapeutics Inc | Topical application and transdermal delivery of botulinum toxins |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US20060073208A1 (en) | 2004-10-01 | 2006-04-06 | Allergan, Inc. | Cosmetic neurotoxin compositions and methods |
| US7964630B2 (en) | 2004-11-02 | 2011-06-21 | Dsm Ip Assets B.V. | Topical application agents against mimic and age-related wrinkles |
| KR20070110402A (ko) | 2005-03-03 | 2007-11-16 | 레반스 테라퓨틱스 | 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법 |
| ES2362301T3 (es) * | 2005-03-03 | 2011-07-01 | Revance Therapeutics, Inc. | Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido. |
| ES2259928B1 (es) * | 2005-04-08 | 2007-11-01 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales. |
| WO2007059528A2 (en) | 2005-11-17 | 2007-05-24 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| CN102408470A (zh) * | 2005-12-23 | 2012-04-11 | 洛桑大学 | 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽 |
| ES2322882B1 (es) | 2006-10-25 | 2010-04-22 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal. |
| EP1992332A1 (de) | 2007-05-08 | 2008-11-19 | Tupperware Products S.A. | Kosmetische Anti-Aging-Hautpflegezusammensetzungen |
| ES2356883B1 (es) * | 2008-07-24 | 2012-02-22 | Bcn Peptides, S.A. | Composición para el tratamiento del dolor y/o la inflamación. |
| JP5782439B2 (ja) * | 2009-07-24 | 2015-09-24 | リポテック, エセ.ア.Lipotec, S.A. | 筋肉収縮を抑制する化合物 |
| US20130078295A1 (en) * | 2010-06-09 | 2013-03-28 | Lipotec S.A. | Skin antiaging treatment |
| US20110305735A1 (en) | 2010-06-09 | 2011-12-15 | Lipotec, S.A. | Skin antiaging treatment |
| ES2385683B1 (es) * | 2010-10-18 | 2013-10-07 | Bcn Peptides, S.A. | Composiciones para el tratamiento del dolor y/o la inflamación. |
| WO2013070808A1 (en) | 2011-11-07 | 2013-05-16 | Feng Tian | Peptide-based compounds as inhibitors of neurotransmitter secretion |
| ES2424294B1 (es) | 2012-03-22 | 2014-07-21 | Lipotec, S.A. | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas |
| EP2649984A1 (de) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Verbindungen zur Hemmung neuronaler Exozytose |
| ES2660901T3 (es) | 2012-04-13 | 2018-03-26 | Lubrizol Advanced Materials, Inc. | Compuestos que inhiben la exocitosis neuronal (II) |
| US10149812B2 (en) | 2012-04-13 | 2018-12-11 | Activen | Cosmetic composition comprising a muconopeptide |
| EP2649985A1 (de) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Verbindungen zur Hemmung neuronaler Exozytose (III) |
| EP2649983A1 (de) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Verbindungen zur Hemmung neuronaler Exozytose (II) |
| WO2013156064A1 (en) | 2012-04-17 | 2013-10-24 | Activen | Anti-wrinkles cosmetic composition comprising a mu-conopeptide |
| US20160250298A1 (en) | 2013-11-01 | 2016-09-01 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
| CA2965525A1 (en) | 2014-10-31 | 2016-05-06 | Lubrizol Advanced Materials, Inc. | Thermoplastic polyurethane film for delivery of active agents to skin surfaces |
| CN104478991B (zh) * | 2014-12-10 | 2018-06-19 | 深圳市维琪医药研发有限公司 | 一种新型多肽化合物及其制备方法和其医药应用 |
| CN104829691B (zh) * | 2015-05-19 | 2018-11-02 | 山西锦波生物医药股份有限公司 | 除皱短肽及其制备方法 |
| EP3371238A1 (de) | 2015-11-05 | 2018-09-12 | Lubrizol Advanced Materials, Inc. | Thermoformbare hydrogelzusammensetzungen mit doppeltem netz |
| AU2019228281B2 (en) | 2018-02-27 | 2024-06-13 | Lipotrue, S.L. | Peptides and compositions for use in cosmetics and medicine |
| ES3060502T3 (en) | 2018-06-13 | 2026-03-26 | Acraf | Peptides having inhibitory activity on neuronal exocytosis |
| BR112021002381A2 (pt) | 2018-08-10 | 2021-05-11 | Lubrizol Advanced Materials, Inc. | composto, combinação, composição, uso de um composto, e, método de tratamento e/ou cuidado cosmético, não terapêutico e/ou cuidado da pele, cabelo, unhas e/ou membranas mucosas de um sujeito |
| CN118561963A (zh) | 2018-10-16 | 2024-08-30 | 格罗制药公司 | 烟碱乙酰胆碱受体肽拮抗剂芋螺毒素组合物及相关方法 |
| MX2020014330A (es) * | 2018-12-26 | 2021-03-09 | Caregen Co Ltd | Composicion para relajacion muscular. |
| EP4144337B1 (de) | 2021-09-02 | 2024-08-07 | Guangzhou Jiyan Cosmetics Technology Co. Ltd. | Kosmetische zusammensetzung aus vitis vinifera |
| CN113826764B (zh) * | 2021-09-24 | 2024-07-12 | 江苏三仪生物工程有限公司 | 一种大豆小肽螯合铁的制备方法 |
| EP4230638A1 (de) * | 2022-02-16 | 2023-08-23 | Lipotrue, S.L. | Peptide und zusammensetzungen zur verwendung in kosmetika |
| WO2023161264A1 (en) | 2022-02-23 | 2023-08-31 | Prospera Biotech, S.L. | Compositions for treating hyperhidrosis |
| EP4501944A4 (de) | 2022-03-28 | 2025-10-08 | Shenzhen Winkey Tech Co Ltd | Polypeptid und kosmetische zusammensetzung oder pharmazeutische zusammensetzung und verwendung davon |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169074B1 (en) * | 1996-03-18 | 2001-01-02 | The Regents Of The University Of California | Peptide inhibitors of neurotransmitter secretion by neuronal cells |
| ES2160485B1 (es) * | 1999-04-23 | 2002-05-16 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
-
1999
- 1999-04-23 ES ES009900844A patent/ES2160485B1/es not_active Expired - Fee Related
-
2000
- 2000-02-18 US US10/030,485 patent/US7015192B1/en not_active Expired - Lifetime
- 2000-02-18 BR BR0011152-0A patent/BR0011152A/pt not_active IP Right Cessation
- 2000-02-18 WO PCT/ES2000/000058 patent/WO2000064932A1/es not_active Ceased
- 2000-02-18 AT AT00905076T patent/ATE338062T1/de active
- 2000-02-18 AU AU26729/00A patent/AU2672900A/en not_active Abandoned
- 2000-02-18 EP EP00905076A patent/EP1180524B2/de not_active Expired - Lifetime
- 2000-02-18 CA CA2370289A patent/CA2370289C/en not_active Expired - Lifetime
- 2000-02-18 DE DE60030429T patent/DE60030429T3/de not_active Expired - Lifetime
- 2000-02-18 JP JP2000614281A patent/JP4363556B2/ja not_active Expired - Lifetime
- 2000-02-18 PT PT00905076T patent/PT1180524E/pt unknown
- 2000-02-18 BR BRPI0011152A patent/BRPI0011152B8/pt unknown
- 2000-02-18 DK DK00905076.6T patent/DK1180524T4/da active
-
2006
- 2006-01-09 US US11/327,952 patent/US7473679B2/en not_active Expired - Fee Related
-
2009
- 2009-06-17 JP JP2009144480A patent/JP4892037B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1180524T3 (da) | 2006-12-11 |
| US20060276392A1 (en) | 2006-12-07 |
| JP2009221223A (ja) | 2009-10-01 |
| JP4892037B2 (ja) | 2012-03-07 |
| CA2370289A1 (en) | 2000-11-02 |
| PT1180524E (pt) | 2007-01-31 |
| WO2000064932A1 (es) | 2000-11-02 |
| DK1180524T4 (da) | 2010-10-25 |
| JP4363556B2 (ja) | 2009-11-11 |
| US7473679B2 (en) | 2009-01-06 |
| EP1180524B2 (de) | 2010-07-07 |
| BRPI0011152B8 (pt) | 2022-05-10 |
| DE60030429T2 (de) | 2007-10-31 |
| BR0011152A (pt) | 2002-02-19 |
| DE60030429T3 (de) | 2012-01-12 |
| JP2002542777A (ja) | 2002-12-17 |
| US7015192B1 (en) | 2006-03-21 |
| EP1180524B1 (de) | 2006-08-30 |
| ES2160485A1 (es) | 2001-11-01 |
| BRPI0011152B1 (pt) | 2018-03-13 |
| DE60030429D1 (de) | 2006-10-12 |
| EP1180524A1 (de) | 2002-02-20 |
| AU2672900A (en) | 2000-11-10 |
| ES2160485B1 (es) | 2002-05-16 |
| CA2370289C (en) | 2011-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60030429D1 (de) | Neuronale, die exozytose hemmende peptide und diese enthaltende kosmetische und pharmazeutische zusammensetzungen | |
| ATE338771T1 (de) | Antagonisten des intestinotrophen glp-2 peptides | |
| ATE280826T1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| YU46097A (sh) | Nova klasa estara i njihove farmaceutske smeše | |
| FI962557A0 (fi) | PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa | |
| DE69532996D1 (de) | Peptidanaloge des menschlichen basischen myelinproteins | |
| LV10720A (lv) | Peptidi un farmaceitiska kompozicija uz to bazes | |
| HUP0001293A1 (hu) | Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására | |
| ID21956A (id) | Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut | |
| DE69710496D1 (de) | Haarbehandlungsmittel enthaltend einen aminosäure-metallkomplex | |
| ATE396205T1 (de) | Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe | |
| DK2380583T3 (da) | Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser | |
| NO20001869L (no) | FremgangsmÕte for behandling av Alzheimers sykdom | |
| CA2334941A1 (en) | Tnf-derived peptides for use in treating oedema | |
| ATE3416T1 (de) | Pharmakologisch aktive peptide und diese enthaltende arzneimittel. | |
| DE69503724D1 (de) | L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen | |
| ATE233812T1 (de) | Peptide mit pronociceptiveigenschaften | |
| PT655244E (pt) | Composicao a base de acidos aminados para o tratamento de infeccoes | |
| DE69334281D1 (de) | TCF-II enthaltende medizinische Zusammensetzung | |
| NO20002001L (no) | Peptider i stand til Õ inhibere interaksjonen mellom preseniliner og <beta>-amyloidpeptidet eller dettes forløper | |
| TR199501328A2 (tr) | Alzheimer peptidi. | |
| ATE31418T1 (de) | Arzneimittel, welche tripeptide enthalten. | |
| FR2704394B1 (fr) | Complément nutritionnel absorbable pour le traitement des cheveux et des ongles. | |
| FR2718028B1 (fr) | Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des hydrolysats peptidiques modifiés. | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1180524 Country of ref document: EP |